<unk>  is a Thrombopoietin Receptor Agonist that is FDA approved for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.   Common adverse reactions include abdominal pain, diarrhea, indigestion, nausea, arthralgia, backache, myalgia, pain in limb, dizziness, headache, insomnia, paresthesia, epistaxis, upper respiratory infection, fatigue.
Romiplostim
Edrecolomab
Sargramostim
Arcitumomab
Tbo-filgrastim
Abagovomab
Tildrakizumab
Catumaxomab